ILMN - Illumina, Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
As of May 15, 2026: spot at $143.19, ATM IV 41.7%, max pain $130.00, net GEX $1.9M.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Market Cap
- $21.94B
- P/E Ratio
- 26.01
- Beta
- 1.42
- 52-Week Range
- 78.55-155.53
- CEO
- Jacob Thaysen
- Employees
- 8,970
- IPO Date
- Jul 28, 2000
- Exchange
- NASDAQ
What ILMN Looks Like to Options Traders Today
IV rank of 16.0% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($1.9M) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (-0.017) is roughly flat across the wings.
What This Page Covers
The ILMN overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked ILMN overview questions
- What is ILMN?
- ILMN is the ticker symbol for Illumina, Inc., a listed security. Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Listed on NASDAQ. ILMN is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the ILMN options snapshot look like today?
- As of May 15, 2026, the ILMN options snapshot shows spot at $143.19, ATM IV 41.7%, IV rank 16.0%, max pain $130.00, net GEX $1.9M, expected move 11.96%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are ILMN's key statistics?
- Illumina, Inc. (ILMN) carries a market capitalization of $21.94B, trailing P/E ratio of 26.01, beta of 1.42 relative to the broader market, 52-week range of 78.55-155.53. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does ILMN belong to?
- Illumina, Inc. operates in the Healthcare sector, in the Medical - Diagnostics & Research industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare ILMN's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the ILMN data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).